Clarapath, Inc. is a U.S. medical-technology company developing robotic automation systems for anatomical pathology and histology workflows, including tissue processing and slide preparation. Its products are intended for hospital, clinical, and pathology laboratories to improve the efficiency and consistency of diagnostic specimen preparation.
Subscribe to see Clarapath, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Clarapath, Inc. is a medical devices company headquartered in United States. Its most recent funding round, Series B, raised $36M in July 2024.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $36M | 8 named | |
| SEC Form D filing | $36M | — | |
| Series B | $32M | 8 named | |
| SEC Form D filing | $4.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.